Cleared Traditional

K231084 - TearCare MGX System (FDA 510(k) Clearance)

Dec 2023
Decision
254d
Days
Class 2
Risk

K231084 is an FDA 510(k) clearance for the TearCare MGX System. This device is classified as a Eyelid Thermal Pulsation System (Class II - Special Controls, product code ORZ).

Submitted by Sight Sciences, Inc. (Menlo Park, US). The FDA issued a Cleared decision on December 27, 2023, 254 days after receiving the submission on April 17, 2023.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.5200. Therapeutic Application Of Heat And Massage To The Eyelids..

Submission Details

510(k) Number K231084 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 2023
Decision Date December 27, 2023
Days to Decision 254 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code ORZ - Eyelid Thermal Pulsation System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.5200
Definition Therapeutic Application Of Heat And Massage To The Eyelids.